Posted by linkadge on September 27, 2005, at 15:37:52
In reply to Re: Triple Reuptake Inhibitors - Race to Market, posted by SLS on September 27, 2005, at 10:30:32
Dispite the theories of serotonin in depression, most SSRI's have an underlying dopaminergic mechanism.
One study showed that a d2 blocker abolished the AD effect of SSRI's wheras it did not induce depression in normals.
A triple uptake inhibitor would be nice. I responded well to SJW. I think its hypeforin, (or hypercin) is a triple uptake inhibitor.
If effexor truely does have a higher responce rate than SSRI's, then it stands to reason that broader specrum may be superior.
Linkadge
poster:linkadge
thread:560146
URL: http://www.dr-bob.org/babble/20050927/msgs/560248.html